
China Market Entry and Market Access: Go / No-Go Decisions for Pharma, Biotech and Medtech
SILREAL helps Western life-sciences leadership decide whether, when and how to enter or expand in China. We assess policy, regulatory pathways, reimbursement, procurement and partner risk before capital is committed. The outcome is a go / no-go decision with the evidence gaps, commercial assumptions and conditions for proceeding stated.
Our Expertise
We help life science and healthcare companies enter new markets with tailored go-to-market strategies, competitive insights, and regulatory alignment that drive sustainable growth.
China Market Entry Strategy
-
Unmet-need analysis & competitive mapping
-
Phased go-to-market roadmaps + KPI dashboards
Location Analysis & Risk Mitigation
-
Benchmarking of China’s innovation hubs (Beijing, Shanghai, Shenzhen, Suzhou)
-
Regulatory, IP, supply-chain and reimbursement risk scoring
Partner Search & Localization
-
Shortlisting & due-diligence of distributors, CMOs, CROs, hospitals
-
Tech-transfer and licensing support for compliant scale-up
Strategic Delegation Trips
-
Curating C-suite visits and policy roundtables to accelerate stakeholder trust
-
Post-trip action plans and follow-up facilitation
Our Expertise
We help life science and healthcare companies enter new markets with tailored go-to-market strategies, competitive insights, and regulatory alignment that drive sustainable growth.
China Market Entry Strategy
-
Unmet-need analysis & competitive mapping
-
Phased go-to-market roadmaps + KPI dashboards
Location Analysis & Risk Mitigation
-
Benchmarking of China’s innovation hubs (Beijing, Shanghai, Shenzhen, Suzhou)
-
Regulatory, IP, supply-chain and reimbursement risk scoring
Partner Search & Localization
-
Shortlisting & due-diligence of distributors, CMOs, CROs, hospitals
-
Tech-transfer and licensing support for compliant scale-up
Strategic Delegation Trips
-
Curating C-suite visits and policy roundtables to accelerate stakeholder trust
-
Post-trip action plans and follow-up facilitation
Why SILREAL?
Strategic Market Entry Expertise
SILREAL develops tailored go-to-market strategies that address regulatory pathways, reimbursement dynamics, and competitive positioning. We ensure that clients enter China and Europe with clarity, speed, and long-term growth alignment.
In-Depth Market Intelligence
Through comprehensive market and competitor analysis, patient insights, and stakeholder mapping, SILREAL provides the evidence base for confident decision-making. Our data-driven approach minimizes risks and maximizes opportunities.
Documented mandates
The China market strategy for ESA Grimma's hospital segment and the Nantong location analysis for a Saarland innovation hub are documented in the case studies below.
Why SILREAL?
Strategic Market Entry Expertise
SILREAL develops tailored go-to-market strategies that address regulatory pathways, reimbursement dynamics, and competitive positioning. We ensure that clients enter China and Europe with clarity, speed, and long-term growth alignment.
In-Depth Market Intelligence
Through comprehensive market and competitor analysis, patient insights, and stakeholder mapping, SILREAL provides the evidence base for confident decision-making. Our data-driven approach minimizes risks and maximizes opportunities.
Documented mandates
The China market strategy for ESA Grimma's hospital segment and the Nantong location analysis for a Saarland innovation hub are documented in the case studies below.
